Brandinium

Trademark search for:

STAXYN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2008-10-24 — Application filed
  • 2008-10-28 — Application filed
  • 2008-11-03 — Approved for pub - principal register
  • 2008-11-03 — Assigned to examiner
  • 2008-11-07 — Assigned to lie
  • 2008-11-07 — Law office publication review completed
  • 2008-11-26 — Notice of publication
  • 2008-12-16 — Published for opposition
  • 2009-01-07 — Extension of time to oppose received
  • 2009-03-05 — Attorney/dom.rep.revoked and/or appointed
  • 2009-03-05 — Teas revoke/app/change addr of atty/dom rep received
  • 2009-03-23 — Teas post publication amendment received
  • 2009-03-26 — Assigned to petition staff
  • 2009-03-27 — Amendment/petition after approval for pub entered
  • 2009-05-06 — Notice of publication
  • 2009-05-26 — Published for opposition
  • 2009-08-18 — Noa mailed - sou required from applicant
  • 2009-10-26 — Teas change of correspondence received
  • 2010-01-14 — Sou teas extension received
  • 2010-01-14 — Sou extension 1 filed
  • 2010-01-14 — Sou extension 1 granted
  • 2010-05-13 — Teas change of correspondence received
  • 2010-07-08 — Sou teas extension received
  • 2010-07-08 — Sou extension 2 filed
  • 2010-08-12 — Case assigned to intent to use paralegal
  • 2010-08-12 — Sou extension 2 granted
  • 2010-08-13 — Notice of approval of extension request e-mailed
  • 2011-01-13 — Sou teas extension received
  • 2011-01-13 — Sou extension 3 filed
  • 2011-01-19 — Sou extension 3 granted
  • 2011-01-20 — Notice of approval of extension request e-mailed
  • 2011-08-02 — Sou teas extension received
  • 2011-08-02 — Teas statement of use received
  • 2011-08-02 — Use amendment filed
  • 2011-08-02 — Sou extension 4 filed
  • 2011-08-09 — Statement of use processing complete
  • 2011-08-09 — Sou extension 4 granted
  • 2011-08-10 — Notice of approval of extension request e-mailed
  • 2011-08-15 — Allowed principal register - sou accepted
  • 2011-08-29 — Law office registration review completed
  • 2011-08-29 — Assigned to lie
  • 2011-08-30 — Notice of acceptance of statement of use e-mailed
  • 2011-10-04 — Registered-principal register
  • 2011-10-12 — Teas section 7 request received
  • 2011-10-17 — Case assigned to post registration paralegal
  • 2011-10-19 — Correction under section 7 - processed
  • 2013-03-25 — Attorney/dom.rep.revoked and/or appointed
  • 2013-03-25 — Teas revoke/app/change addr of atty/dom rep received
  • 2013-10-09 — Automatic update of assignment of ownership
  • 2016-10-04 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2017-09-19 — Teas section 8 & 15 received
  • 2017-10-13 — Case assigned to post registration paralegal
  • 2017-10-13 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2017-10-13 — Notice of acceptance of sec. 8 & 15 - e-mailed
  • 2018-02-16 — Attorney/dom.rep.revoked and/or appointed
  • 2018-02-16 — Teas revoke/app/change addr of atty/dom rep received
  • 2020-10-04 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2022-04-15 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2022-04-15 — Final status recorded

Owner Information

BAYER AKTIENGESELLSCHAFT
LEVERKUSEN DE
Glaxo Group Limited
Greenford, Middlesex GB
Glaxo Group Limited
Greenford, Middlesex GB
Glaxo Group Limited
Greenford, Middlesex GB

Correspondent

Vanessa A. Ignacio Lowenstein Sandler LLP
One Lowenstein Drive
bayertrademarkus@bayer.com
Roseland, NJ 07068

Filing Details

Filing Date:
2008-10-24
Status Date:
2022-04-15
Category:
Pharmaceuticals
Filing Year:
2008

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.